Open Orphan #ORPH – hVIVO to present at 2020 ERS International Congress September 7, 2020 – Posted in: Open Orphan (ORPH)

Open Orphan plc (ORPH), a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge clinical trials is pleased to announce that its subsidiary, hVIVO, will be presenting at the European Respiratory Society Congress being held on 7th – 9th September, 2020. The presentation will discuss the safety and pathogenicity results of a new RSV infection model in older adults aged 60-75-year-old. This…

Continue reading